(https://www.wheelingeyecare.com/what-is-diabetic-retinopathy/)

Introduction

Diabetic retinopathy, a leading cause of vision loss among adults, poses a significant threat to the quality of life for millions worldwide. As the population ages and diabetes rates continue to soar, the search for innovative treatments becomes more urgent. In recent years, a promising therapy has emerged from an unlikely source: red light. This article delves into the science behind red light therapy, its potential efficacy in treating diabetic retinopathy, safety considerations, and what patients can expect moving forward.

The Science Behind Red Light Therapy

At the core of red light therapy is the concept of photobiomodulation (PBM), a process in which specific wavelengths of light interact with cellular structures to stimulate healing and improve function. The retina, rich in light-sensitive cells, is particularly responsive to this type of therapy. Research has shown that exposure to red light can stimulate mitochondria, the cellular powerhouses, to increase energy production and reduce oxidative stress[1].

Red light in the 670 nm range has been found to penetrate deep into the retina, where it can stimulate Cytochrome C Oxidase, a key enzyme in the mitochondrial respiratory chain. This interaction can lead to increased adenosine triphosphate (ATP) production, the energy currency of cells, and a reduction in reactive oxygen species (ROS), which are implicated in retinal damage[2].

Fig 1. Red Light Therapy

(https://redlightman.com/blog/red-light-restores-vision-and-eye-health/)

Efficacy in Diabetic Retinopathy

The potential of red light therapy for diabetic retinopathy lies in its ability to target the root causes of the condition. Diabetic retinopathy is characterized by damage to the retina's blood vessels and neurons, leading to vision loss. By improving mitochondrial function and reducing oxidative stress, red light therapy may slow the progression of the disease and protect retinal cells.

A pilot study published in the Journals of Gerontology demonstrated that daily exposure to 670 nm light for two weeks significantly improved retinal function in participants over the age of 40[3]. Another study indicated that red light therapy could potentially reverse some cellular damage caused by blue light, which is increasingly being associated with retinal damage[4].While this study did not specifically focus on diabetic retinopathy, it provides a compelling foundation for further research.

Safety Considerations

The safety profile of red light therapy is a significant advantage, as it is non-invasive and does not require surgery or medication. The use of red light wavelengths (typically 630–1000 nm) is considered safe as they pose minimal risk of retinal damage[5]. Moreover, unlike some other forms of light therapy, red light therapy does not seem to cause harmful thermal effects or disrupt normal retinal function.

However, as with any therapeutic approach, safety must be monitored, and patients should be advised to avoid looking directly at the light source to prevent any potential ocular damage.

Availability and Future Prospects

Red light therapy is not yet widely available for the treatment of diabetic retinopathy, but the technology is advancing rapidly. The American Academy of Ophthalmology advises caution, emphasizing the need for more data before red light therapy can be considered a standard treatment for ocular diseases or aging eyes[6].

Conclusion

The prospect of using red light therapy to treat diabetic retinopathy is an exciting development in the field of ophthalmology. With its potential to improve mitochondrial function, reduce oxidative stress, and enhance overall retinal health, red light therapy offers a non-invasive and potentially effective treatment option for patients. As research continues, the hope is that this therapy will become a standard part of care for those living with diabetic retinopathy.

References

1. Tang J, Du Y, Lee CA, Talahalli R, Eells JT, Kern TS. Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest Ophthalmol Vis Sci. 2013;54:3681–3690.

2. Shinhmar H, Grewal M, Sivaprasad S, Hogg C, Chong V, Neveu M, Jeffery G. Optically Improved Mitochondrial Function Redeems Aged Human Visual Decline. J Gerontol A Biol Sci Med Sci, 2020, Vol. 75, No. 9, e49–e52.

3. Grewal MK, Sivapathasuntharam C, Chandra S, Gurudas S, Chong V, Bird A, Jeffery G, Sivaprasad S. A Pilot Study Evaluating the Effects of 670 nm Photobiomodulation in Healthy Ageing and Age-Related Macular Degeneration. J Clin Med. 2020;9(4):1001.

4. Begum R, Powner MB, Hudson N, Hogg C, Jeffery G. Treatment with 670 nm light up regulates cytochrome c oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS ONE 8: e57828.

5. American Academy of Ophthalmology. (n.d.). Red Light Therapy for Protecting and Healing Eyes. Retrieved from https://www.aao.org/eye-health/news/red-light-protect-aging-eyes-rlt-pbm-near-infrared

6. American Optometric Association. (n.d.). Can red light recharge the retina? Retrieved from https://www.aoa.org/news/clinical-eye-care/health-and-wellness/recharging-the-retina?sso=y